82 FR 8427 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 82, Issue 15 (January 25, 2017)
Centers for Disease Control and Prevention
Federal Register Volume 82, Issue 15 (January 25, 2017)
| Page Range | 8427-8427 | |
| FR Document | 2017-01628 |
[Federal Register Volume 82, Number 15 (Wednesday, January 25, 2017)] [Notices] [Page 8427] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-01628] [[Page 8427]] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of application in response to Funding Opportunity Announcement (FOA) PAR 15-303, Occupational Safety and Health Education and Research Centers (ERC). Times and Dates: 8:00 a.m.-6:00 p.m., EST, February 22, 2017 (Closed), 8:00 a.m.-6:00 p.m., EST, February 23, 2017 (Closed), 8:00 a.m.-6:00 p.m., EST, February 24, 2017 (Closed). Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, Virginia 22314, Telephone: (703) 837-0440. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ``Occupational Safety and Health Education and Research Centers (ERC)'', PAR 15-303. Contact Person for More Information: Michael Goldcamp, Ph.D., Scientific Review Officer, CDC, 1095 Willowdale Road, Morg Building H, Room 1806, Mailstop 1808, Morgantown, West Virginia, Telephone: (304) 285-5951, [email protected]. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017-01628 Filed 1-24-17; 8:45 am] BILLING CODE 4163-18-P
![Federal Register / Vol. 82, No. 15 / Wednesday, January 25, 2017 / Notices 8427
DEPARTMENT OF HEALTH AND (Pub. L. 92–463), the Centers for Disease outbreak; Dengue virus vaccines; Polio
HUMAN SERVICES Control and Prevention (CDC) announce Eradication Initiative; Measles and
the following meeting of the Rubella Elimination Initiative; adult
Centers for Disease Control and aforementioned committee. immunization and vaccine supply. A
Prevention Times and Dates: 8:00 a.m.–5:40 p.m., recommendation vote is scheduled for
EST, February 22, 2017; 8:00 a.m.–1:00 hepatitis B vaccine and influenza. A
Disease, Disability, and Injury p.m., EST, February 23, 2017. Vaccines for Children (VFC) vote is
Prevention and Control Special Place: CDC, Tom Harkin Global scheduled for hepatitis B vaccine.
Emphasis Panel (SEP): Initial Review Communications Center, 1600 Clifton Agenda items are subject to change as
In accordance with Section 10(a)(2) of Road NE., Building 19, Kent ‘‘Oz’’ priorities dictate.
the Federal Advisory Committee Act Nelson Auditorium, Atlanta, Georgia Contact Person for More Information:
30329. Stephanie Thomas, National Center for
(Pub. L. 92–463), the Centers for Disease
Status: Open to the public, limited Immunization and Respiratory Diseases,
Control and Prevention (CDC)
only by the space available. Time will CDC, 1600 Clifton Road NE., MS–A27,
announces a meeting for the initial be available for public comment. The
review of application in response to Atlanta, Georgia 30329, telephone 404/
public is welcome to submit written 639–8836; Email ACIP@CDC.GOV.
Funding Opportunity Announcement comments in advance of the meeting.
(FOA) PAR 15–303, Occupational Safety The Director, Management Analysis
Comments should be submitted in and Services Office, has been delegated
and Health Education and Research writing by email to the contact person
Centers (ERC). the authority to sign Federal Register
listed below. The deadline for receipt notices pertaining to announcements of
Times and Dates: 8:00 a.m.–6:00 p.m., EST, February 13, 2017. All requests must
February 22, 2017 (Closed), 8:00 a.m.–6:00 meetings and other committee
contain the name, address, and management activities for both the
p.m., EST, February 23, 2017 (Closed), 8:00
a.m.–6:00 p.m., EST, February 24, 2017 organizational affiliation of the speaker, Centers for Disease Control and
(Closed). as well as the topic being addressed. Prevention and the Agency for Toxic
Place: Hilton Alexandria Old Town, 1767 Written comments should not exceed Substances and Disease Registry.
King Street, Alexandria, Virginia 22314, one single-spaced typed page in length
Telephone: (703) 837–0440. and delivered in 3 minutes or less. Elaine L. Baker,
Status: The meeting will be closed to the Please note that the public comment Director, Management Analysis and Services
public in accordance with provisions set period may end before the time Office, Centers for Disease Control and
forth in Section 552b(c)(4) and (6), Title 5 indicated, following the last call for Prevention.
U.S.C., and the Determination of the Director, [FR Doc. 2017–01624 Filed 1–24–17; 8:45 am]
comments. Members of the public who
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463. wish to provide public comments BILLING CODE 4160–18–P
Matters for Discussion: The meeting will should plan to attend the public
include the initial review, discussion, and comment session at the start time listed.
evaluation of applications received in Written comments received in advance DEPARTMENT OF HEALTH AND
response to ‘‘Occupational Safety and Health of the meeting will be included in the HUMAN SERVICES
Education and Research Centers (ERC)’’, PAR official record of the meeting.
15–303. The meeting will be webcast live via Centers for Disease Control and
Contact Person for More Information: the World Wide Web; for instructions Prevention
Michael Goldcamp, Ph.D., Scientific Review and more information on ACIP please
Officer, CDC, 1095 Willowdale Road, Morg Disease, Disability, and Injury
Building H, Room 1806, Mailstop 1808, visit the ACIP Web site: http://
Prevention and Control Special
Morgantown, West Virginia, Telephone: (304) www.cdc.gov/vaccines/acip/index.html.
Purpose: The committee is charged Emphasis Panel (SEP): Initial Review
285–5951, EHG8@CDC.GOV.
The Director, Management Analysis and with advising the Director, CDC, on the In accordance with Section 10(a)(2) of
Services Office, has been delegated the use of immunizing agents. In addition, the Federal Advisory Committee Act
authority to sign Federal Register notices under 42 U.S.C. 1396s, the committee is (Pub. L. 92–463), the Centers for Disease
pertaining to announcements of meetings and mandated to establish and periodically Control and Prevention (CDC)
other committee management activities, for review and, as appropriate, revise the announces a meeting for the initial
both the Centers for Disease Control and
list of vaccines for administration to review of applications in response to
Prevention and the Agency for Toxic
Substances and Disease Registry. vaccine-eligible children through the Funding Opportunity Announcement
Vaccines for Children (VFC) program, (FOA), RFA–CE–12–0010501SUPP16,
Elaine L. Baker, along with schedules regarding dosing Grants for Injury Prevention and
Director, Management Analysis and Services interval, dosage, and contraindications Control.
Office, Centers for Disease Control and to administration of vaccines. Further, Times and Dates: 8:00 a.m.–5:00 p.m.,
Prevention. under provisions of the Affordable Care EST, February 21–22, 2017 (Closed).
[FR Doc. 2017–01628 Filed 1–24–17; 8:45 am] Act, section 2713 of the Public Health Place: The Georgian Terrace, 659
BILLING CODE 4163–18–P Service Act, immunization Peachtree Street NE., Atlanta, GA 30308.
recommendations of the ACIP that have Status: The meeting will be closed to
been approved by the Director of the the public in accordance with
DEPARTMENT OF HEALTH AND Centers for Disease Control and provisions set forth in Section 552b(c)
HUMAN SERVICES Prevention and appear on CDC (4) and (6), Title 5 U.S.C., and the
immunization schedules must be Determination of the Director,
mstockstill on DSK3G9T082PROD with NOTICES
Centers for Disease Control and covered by applicable health plans. Management Analysis and Services
Prevention Matters for Discussion: The agenda Office, CDC, pursuant to Public Law 92–
will include discussions on: 463.
Advisory Committee on Immunization
Meningococcal vaccine; influenza; Matters for Discussion: The meeting
Practices (ACIP)
hepatitis B vaccine; herpes zoster will include the initial review,
In accordance with section 10(a)(2) of vaccine; vaccine safety; yellow fever discussion, and evaluation of
the Federal Advisory Committee Act vaccine; Zika virus vaccine; mumps applications received in response to
VerDate Sep<11>2014 20:29 Jan 24, 2017 Jkt 241001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\25JAN1.SGM 25JAN1](https://thefederalregister.org/doc/82_FR_8442/page/1.svg)
Document Created: 2017-01-25 00:08:50
Document Modified: 2017-01-25 00:08:50
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | 8:00 a.m.-6:00 p.m., EST, February 22, 2017 (Closed), 8:00 a.m.-6:00 p.m., EST, February 23, 2017 (Closed), 8:00 a.m.-6:00 p.m., EST, February 24, 2017 (Closed). | |
| FR Citation | 82 FR 8427 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR